Safety and Tolerability of Odanacatib Therapy in Postmenopausal Women with Osteoporosis: Results from the Phase III Long-Term Odanacatib Fracture Trial (LOFT)

Author(s):
Papapoulos, S.; McClung, M.; Langdahl, B.; Saag, K.; Adami, S.; Bone, H.; Villiers, T. de; Kiel, D.; Kung, A.; Kumar, P.; Lim, S.K.; Ling, X.; Lippuner, K.; Mautalen, C.; Nakamura, T.; Reginster, J.Y.; Reid, I.; Rodriguez-Portales, J.A.; Roux, C.; Walliser, J.; Watts, N.; Zanchetta, J.R.; Zerbini, C.A.F.; Fybak-Feiglin, A.; Cohn, D.; Silva, C.A. da; Tilleghem, C.L. de; Santora, A.; Scott, B.; Verbruggen, N.; Leung, A.; Lombardi, A.; Gurner, D.
Published
2014
Publication type
Article / Letter to editor
Date issued
2014-02-28
Language
English
Is part of
Journal of Bone and Mineral Research (2014), Vol. 29, p. S51-S51
hdl
1887/108036